Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structure-Based Probe Reveals the Presence of Large Transthyretin Aggregates in Plasma of ATTR Amyloidosis Patients

JACC Basic to Translational Science(2024)10.1016/j.jacbts.2024.05.013Source: DataRank Database

Structure-Based Probe Reveals the Presence of Large Transthyretin Aggregates in Plasma of ATTR Amyloidosis Patients is a research paper published in JACC Basic to Translational Science (2024). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: goldTopics (8)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Lanie Wang ORCID,Anna Yakubovska ORCID,Qiongfang S. Zhang,Binh A. Nguyen ORCID,Justin L. Grodin ORCID

Live enrichment

PubMed:39444930 PMC:PMC11494390

NHLBI NIH HHS

Grant: DP2 HL163810

NHLBI NIH HHS

Grant: R01 HL160892

National Institutes of Health

Grant: 1S10OD021685-01A1

TEM for UT Southwestern Electron Microscopy Core Facility

National Institutes of Health

Grant: 5R01HL160892-04

IDENTIFYING SUBCLINICAL TRANSTHYRETIN CARDIAC AMYLOIDOSIS IN ASYMPTOMATIC CARRIERS OF THE V122I TTR ALLELE

National Institutes of Health

Grant: 4DP2HL163810-02

Closing the gap between structural biology and translational science for amyloid diseases

NIH

Oregon Health and Science University

American Heart Association Inc

Indiana University

NHLBI

Welch Foundation

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.jacbts.2024.05.013

publisherhttps://api.elsevier.com/content/article/PII:S2452302X24002201?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2452302X24002201?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11494390/pdf/main.pdf

repositoryhttps://doaj.org/article/9891b27218c04f229c2be504322a5678

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

AmyloidBiomarkertransthyretinAmyloidogenic TransthyretinOriginal Research - Preclinical

Sustainable Development Goals

SDG 3: 3. Good health